For the idea behind this weekly series of posts, see the preamble to the 1st edition.
Not the age, it’s the mileage. “@dpinsen: MT @MikeZaccardi: RT @coffeygrinds: Snaps Of Whitney Houston last night bit.ly/xvos7B“
— Andy Swan (@AndySwan) February 12, 2012

Twitter Breaks News of Whitney Houston Death 27 Minutes Before Press – on.mash.to/y2tmUS
— Pete Cashmore [...]

For the last two weeks, I’ve been unplugging from the Internet for most of the weekend. I check my e-mails whenever I get rolling on Saturday, and then sign off until Monday. I’ve come to enjoy the respite. Last weekend, after reading the hard copy version of Saturday’s Financial Times, and a section or two [...]

Some new stocks added to Short Screen last week:
Manufacturing: CDTID, MASC, MUSA, JCLY.PK, CGLA, JGBO, INFN, SBAY, CBPO, LEG, VALV, SCOK
Non-manufacturing: LIVE, LTBR, NCIT, DWRI.PK, VQ, CTRN, APEI, LPS, PROJ, NWSA

There are few items I’ve come across over the last week that I’ve been thinking of blogging about, but the spirit hasn’t moved me to do so yet. In the meantime, feel free to share your thoughts in the comment thread below — what’s on your mind now, suggestions for future posts, whatever. Consider this [...]

Current version of Portfolio Armor for iPhone icon:

Some sample financial iPhone app icons:

Portfolio Armor feedback
One of the key ideas in the book Getting Real by 37 Signals is to not over-build a web app: Build a useful tool, but don’t cram it with too many additional features at first. Another idea in the book, if memory serves, is to not compulsively save feedback and feature requests; instead, [...]

A friend who works in the industry had spoken positively about Trubion Pharmaceuticals a few months back, and I added it to my watch list, figuring it I might buy after a significant market correction. After the close today, the company announced it was getting bought out by Emergent BioSolutions. It was up ~50% after [...]